A Pure-Play Quantum Hardware Bet With Real Technical Optionality and Very Little Margin for Error

Rating: Highly Speculative / Selective buy on pullbacks

Style: Quantum hardware optionality

Core debate: Is Rigetti becoming a credible superconducting quantum hardware contender with improving commercialization and a much stronger balance sheet, or is the stock still far ahead of the company’s real economic progress?

Executive view

Rigetti looks better today than it did in the prior version of the thesis, mainly because the company now has a fresher proof point: Q1 2026 revenue of $4.4 million, up sharply year over year, helped by Novera system deliveries, while still maintaining $569 million of cash, cash equivalents, and investments and zero debt. That matters because Rigetti had been easier to like as a technology concept than as a business. Q1 does not solve that gap, but it narrows it.

At the same time, the core truth has not changed: this is still a pre-scale quantum hardware company whose valuation depends much more on future technical and commercial milestones than on current fundamentals. The stock is around $18.94 with a market cap of about $6.16 billion, while full-year 2025 revenue was only $7.1 million. That means investors are still underwriting a lot of future success.

Why now — Q1 2026 finally gave the story a better operating datapoint

The biggest update is that Rigetti’s latest quarter was materially better than the old thesis base. In Q1 2026, the company reported $4.4 million of revenue, versus $1.5 million in Q1 2025, driven by Novera and system-related deliveries. It also reported an operating loss of $26.0 million and a non-GAAP net loss of $14.7 million, which shows the business is still far from profitability, but the revenue improvement matters because it provides evidence that commercialization is not purely theoretical.

More importantly, Rigetti ended the quarter with $569 million in cash, cash equivalents, and investments and no debt outstanding. That is a meaningful upgrade versus the company’s earlier risk profile and gives it more freedom to pursue its roadmap without near-term financing pressure. The company’s 10-K also says existing liquidity should fund anticipated operating needs for at least the next twelve months.

What Rigetti does

Rigetti is a full-stack quantum computing company focused on superconducting quantum systems. It designs processors, systems, cloud access, and supporting infrastructure, with the architecture centered on superconducting qubits and a modular scaling strategy. Unlike D-Wave, which is primarily associated with annealing, and unlike IonQ’s trapped-ion approach, Rigetti is essentially a focused bet on superconducting hardware execution.

The strategic idea remains attractive: superconducting quantum hardware is one of the most actively pursued architectures in the field, and Rigetti is trying to differentiate through multi-chip scaling, full-stack control, and faster deployment of practical systems. But because it is much smaller than the largest players pursuing similar architectures, Rigetti must compete through execution quality, not balance-sheet dominance.

How they win

• Rigetti wins only if it proves that its architecture can scale and that customers care enough to buy into that path early. The most important technical-commercial update is that Cepheus-1-108Q is now generally available, including through Rigetti QCS and Amazon Braket, and management is targeting 99.5% median two-qubit gate fidelity by the end of 2026. Rigetti also highlighted 99.9% two-qubit gate fidelity at 28 nanoseconds on a prototype platform, which supports the argument that the technical roadmap is moving in the right direction.
• The second way Rigetti can win is by becoming a credible seller of systems and services to governments, labs, and national computing programs before broad enterprise quantum demand arrives. The company previously announced Novera purchase orders and an $8.4 million order from India’s C-DAC for a 108-qubit on-premises system, and management had already indicated that part of the Novera orders would support strong Q1 year-over-year growth. That is still small in absolute terms, but it is important because it shows real buying behavior, not just pilot hype.

Business model

Rigetti’s model is still early-stage and uneven. Revenue currently comes from system sales, cloud access, research and government-related contracts, and associated services, which means quarter-to-quarter results will remain lumpy. Q1 2026 is a good example: revenue improved sharply because of specific deliveries, not because Rigetti suddenly has a stable recurring-revenue engine.

So the business should still be understood as a milestone-driven hardware commercialization story, not as a mature software or infrastructure platform. The near-term market will continue to care more about system launches, fidelity targets, customer orders, and roadmap execution than about conventional earnings power.

By the numbers

The updated financial picture is now:

• Q1 2026 revenue: $4.4 million
• Q1 2026 operating loss: $26.0 million
• Q1 2026 non-GAAP net loss: $14.7 million
• Cash/investments at Q1 2026 end: $569 million
• Debt: zero.

For context, full-year 2025 was still very small:

• FY2025 revenue: $7.1 million
• Q4 2025 revenue: $1.9 million
• FY2025 GAAP net loss: $216.2 million.

So the update improves the near-term picture, but the company is still in the very early stages of building a real business.

Key drivers

• The first driver is still technical execution. If Rigetti achieves its target of 99.5% median two-qubit fidelity on the 108Q system by year-end 2026, the credibility of the roadmap improves materially. In quantum hardware, these technical milestones often matter as much as revenue.
• The second driver is commercial validation. More Novera shipments, more national-lab and government orders, and broader use of Cepheus-1-108Q through cloud channels would all help move the story from “promising hardware developer” toward “real emerging supplier.”
• The third driver is capital strength relative to peers. Rigetti is still smaller than IonQ on the balance sheet, but having $569 million in liquidity and no debt gives it more time than many investors may realize. That reduces one of the most dangerous risks in deep-tech investing: being right on the technology but underfunded before the market matures.

Risks

• The biggest risk is still valuation. Even after the Q1 update, a market cap of about $6.16 billion versus annual revenue that was only $7.1 million in 2025 remains extremely demanding. The stock still assumes that technical progress will eventually translate into meaningful commercial relevance.
• The second risk is execution risk. Rigetti is competing in one of the hardest technological fields in the world, against much larger and better-capitalized organizations. Even small delays in Cepheus performance, manufacturing, or customer adoption can have an outsized effect on sentiment.
• The third risk is commercial immaturity. One stronger quarter helps, but it does not yet prove that Rigetti has built a durable revenue engine. Investors should still assume that results will be uneven and tied to contract timing.

Bottom line

Bull case: Rigetti is more credible today than it was before the Q1 2026 update. Revenue improved meaningfully, the balance sheet remains strong, Cepheus-1-108Q is now commercially available, and the company continues to hit relevant hardware milestones. If technical progress and customer traction continue together, the stock can keep working.

Bear case: this is still a very expensive stock relative to actual commercial scale. A better quarter does not change the fact that Rigetti remains an early-stage quantum company with heavy losses and a valuation that leaves little room for disappointment.